Kyverna Insider Buying Signals Confidence, Boosts Investor Faith in Biotech Future
Kyverna Therapeutics insider buying shows CEO confidence, aligns exec incentives with long‑term value, and signals strong market‑access prospects for oncology and immunology pipelines.
4 minutes to read